GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (OTCPK:CAKFY) » Definitions » Other Net Income (Loss)

McKesson Europe AG (McKesson Europe AG) Other Net Income (Loss) : $-901 Mil (TTM As of Mar. 2022)


View and export this data going back to 2008. Start your Free Trial

What is McKesson Europe AG Other Net Income (Loss)?

McKesson Europe AG's Other Net Income (Loss) for the six months ended in Mar. 2022 was $-901 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2022 was $-901 Mil.

McKesson Europe AG's quarterly Other Net Income (Loss) increased from Mar. 2020 ($-196 Mil) to Mar. 2021 ($-16 Mil) but then declined from Mar. 2021 ($-16 Mil) to Mar. 2022 ($-901 Mil).

McKesson Europe AG's annual Other Net Income (Loss) increased from Mar. 2020 ($-196 Mil) to Mar. 2021 ($-16 Mil) but then declined from Mar. 2021 ($-16 Mil) to Mar. 2022 ($-901 Mil).


McKesson Europe AG Other Net Income (Loss) Historical Data

The historical data trend for McKesson Europe AG's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG Other Net Income (Loss) Chart

McKesson Europe AG Annual Data
Trend Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.81 -13.79 -195.80 -16.07 -900.88

McKesson Europe AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.81 -13.79 -195.80 -16.07 -900.88

McKesson Europe AG Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2022 was $-901 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


McKesson Europe AG Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson Europe AG (McKesson Europe AG) Business Description

Traded in Other Exchanges
N/A
Address
Stockholmer Platz 1, Stuttgart, BW, DEU, 70137
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (McKesson Europe AG) Headlines

No Headlines